Related Experiment Video
Updated: Aug 7, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
Synthesis and pharmacologic properties of 6-succinylcodeine
E Toro-Goyco1, P C Zenk, U Estrada
1Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
Researchers synthesized 6-succinylcodeine, a less toxic codeine derivative, for affinity chromatography. This compound shows potential for separating codeine receptors, despite altered pharmacological activity upon matrix coupling.
Area of Science:
- Pharmacology
- Biochemistry
- Medicinal Chemistry
Background:
- Developing affinity chromatography ligands is crucial for isolating specific biological targets.
- Codeine-specific receptors are of interest for understanding opioid pathways.
- A pharmacologically active derivative of codeine was needed for ligand synthesis.
Purpose of the Study:
- To synthesize and characterize a codeine derivative, 6-succinylcodeine, for use as an affinity ligand.
- To evaluate the pharmacological properties of 6-succinylcodeine.
- To assess the suitability of 6-succinylcodeine coupled to a matrix for receptor separation.
Main Methods:
- Synthesis of 6-succinylcodeine (Ib) and confirmation of its structure.
- Pharmacological testing in vivo (mice, cats, rhesus monkeys) and in vitro (guinea pig ileum).
- Coupling of 6-succinylcodeine to an aminoalkyl agarose matrix and evaluation of its properties.
Main Results:
- 6-succinylcodeine exhibits reduced toxicity and weaker antitussive effects compared to codeine.
- Antinociceptive and guinea pig ileum effects of 6-succinylcodeine are comparable to codeine.
- The coupled ligand loses, but regains, its ileum contractility inhibition upon hydrolysis, indicating matrix interaction.
Conclusions:
- 6-succinylcodeine is a viable, less toxic derivative for potential affinity chromatography of codeine receptors.
- The modification of pharmacological activity upon matrix coupling requires further investigation for optimal ligand design.
- The study lays groundwork for developing novel tools to study codeine-related biological targets.
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Depolarizing Blockers: Pharmocokinetics
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids

